TH103 — Interim data
1H 2027
Enrollment in the Phase 1b/2 multiple-ascending dose trial of TH103 continues, with preliminary data on track for 1H 2027Source filing
KLRS biotech catalysts & pipeline
KALARIS THERAPEUTICS INC · Data as of 2026-09-08
KALARIS THERAPEUTICS INC · Data as of 2026-09-08
1H 2027
Enrollment in the Phase 1b/2 multiple-ascending dose trial of TH103 continues, with preliminary data on track for 1H 2027Source filing